Ryan Braun’s name discovered in the Biogenesis records

68 Comments

From Jeff Passan and Tim Brown of Yahoo! Sports:

Milwaukee Brewers star Ryan Braun’s name is in records of the Miami-area clinic alleged to have distributed performance-enhancing drugs to a rash of baseball players, and Major League Baseball will investigate the link to the former MVP who tested positive for illegal synthetic testosterone during the 2011 postseason.

Braun was cleared of that 2011 positive test due to what was perceived to be an error in the handling of his urine sample. His name is not listed next to any specific PED transactions in the Biogenesis records, but Major League Baseball will investigate the matter in the hope of learning about the outfielder’s exact level of involvement.

Yankees catcher Francisco Cervelli and Orioles third baseman Danny Valencia were also discovered in the records at the Biogenesis clinic but, like Braun, were not listed in connection with a specific PED.

**********************

UPDATE, 11:21 PM: Braun says in a written statement that he used Bosch for consulting in his successful PED appeal and that he has “nothing to hide” —

“During the course of preparing for my successful appeal last year, my attorneys, who were previously familiar with Tony Bosch, used him as a consultant. More specifically, he answered questions about T/E ratio and possibilities of tampering with samples. There was a dispute over compensation for Bosch’s work, which is why my lawyer and I are listed under ‘moneys owed’ and not on any other list. I have nothing to hide and have never had any other relationship with Bosch. I will fully cooperate with any inquiry into this matter.”

Rockies, Trevor Story agree on two-year, $27.5 million contract

Trevor Story
Matthew Stockman/Getty Images
1 Comment

ESPN’s Jeff Passan reports that the Rockies and shortstop Trevor Story have come to terms on a two-year, $27.5 million deal, buying out his two remaining years of arbitration eligibility.

Story, 27, and the Rockies did not agree on a salary before the deadline earlier this month. Story filed for $11.5 million while the team countered at $10.75 million. The average annual value of this deal — $13.75 million — puts him a little bit ahead this year and likely a little bit behind next year.

This past season in Colorado, Story hit .294/.363/.554 with 35 home runs, 85 RBI, 111 runs scored, and 23 stolen bases over 656 trips to the plate. He also continued to rank among the game’s best defensive shortstops. Per FanGraphs, Story’s 10.9 Wins Above Replacement over the last two seasons is fifth-best among shortstops (min. 1,000 PA) behind Alex Bregman, Francisco Lindor, Xander Bogaerts, and Marcus Semien.

With third baseman Nolan Arenado likely on his way out via trade, one wonders if the same fate awaits Story at some point over the next two seasons.